Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›BioMarin International Limited

Medicines register · Ireland

BioMarin International Limited — licensed medicines

13 medicines held by BioMarin International Limited on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Brineura 150 mg solution for infusion EU/1/17/1192/001

Cerliponase

BioMarin International Limited

—

Kuvan 100 mg powder for oral solution EU/1/08/481/004

Sapropterin hydrochloride

Biomarin International Limited

—

Kuvan 100 mg soluble tablets EU/1/08/481/1-3

Sapropterin dihydrochloride

Biomarin International Limited

—

Kuvan 500 mg powder for oral solution EU/1/08/481/005

Sapropterin hydrochloride

Biomarin International Limited

—

Naglazyme 1 mg/ml concentrate for solution for infusion EU/1/05/324/001

Galsulfase

BioMarin International Limited

—

Palynziq 10 mg Solution for injection EU/1/19/1362/002

PEGVALIASE

Biomarin International Limited

—

Palynziq 2.5 mg Solution for injection EU/1/19/1362/001

PEGVALIASE

Biomarin International Limited

—

Palynziq 20 mg Solution for injection EU/1/19/1362/003-004

PEGVALIASE

Biomarin International Limited

—

ROCTAVIAN 2 × 10^13 vector genomes/mL solution for infusion EU/1/22/1668/001

Valoctocogene Roxaparvovec

Biomarin International Limited

—

Vimizim 1 mg/ml concentrate for solution for infusion EU/1/14/914/001

Rhgalns

Biomarin International Limited

—

Voxzogo 0.4 mg powder and solvent for solution for injection EU/1/21/1577/001

Vosoritide

Biomarin International Limited

—

Voxzogo 0.56 mg powder and solvent for solution for injection EU/1/21/1577/002

Vosoritide

Biomarin International Limited

—

Voxzogo 1.2 mg Powder and solvent for solution for injection EU/1/21/1577/003

Vosoritide

Biomarin International Limited

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines/company/biomarin-international-limited

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.